跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 7,485 条关于
“CB1 receptors”
全部
7,485
临床试验
5,010
药物
904
机构
8
资讯
1,563
去年
CB1 Inhibitors Resurface as Potential Obesity Treatment with Improved Safety Profiles
6个月前
InMed Pharmaceuticals Winds Down BayMedica Operations to Focus on CB1/CB2 Receptor Drug Pipeline
去年
Novel Drug VIP36 Targets CB1 Receptor for Pain Relief Without CNS Side Effects
去年
Skye Bioscience's Nimacimab Phase 2 Trial Reaches 50% Enrollment for Obesity Treatment
去年
FDA Fast-Tracks Novel Drug PP-01 for Cannabis Withdrawal Syndrome Treatment
去年
IGC Pharma Unveils AI-Powered Alzheimer's Platforms at AAIC 2025
去年
Artelo Biosciences' ART27.13 Mimics Cannabis Effects to Combat Cancer-Related Weight Loss
去年
Skye Bioscience Reports Promising Preclinical Data for Nimacimab as Obesity Treatment Ahead of Phase 2a Results
3个月前
PleoPharma Doses First Patient in Pivotal Phase 3 Trial of PP-01 for Cannabis Withdrawal, Presents Phase 2 Data Showing 43% Reduction in Irritability
10个月前
InMed's Alzheimer's Drug Candidate INM-901 Shows Favorable Bioavailability in Large Animal Studies
第 1 页,共 157 页
上一页
下一页